Pharmafile Logo
Pharmafocus logo
Advanced Search

Gene Weaver awarded Gates Foundation grant for programmable gene insertion platform

May 30, 2025
Medical Communications, Research and Development Bill and Melinda Gates Foundation, Gene Weaver, Oncology, Pharmacy, Rare Diseases, funding, gene editing

UK-based biotech Gene Weaver has received $515,000 from the Bill and Melinda Gates Foundation to advance its programmable gene insertion technology …

News

Ochre Bio appoints Elaine Sullivan as senior independent non-executive director

May 30, 2025
Research and Development Infections and infestations, Ochre Bio, Oncology, RNA therapeutics, Rare Diseases, appointment, senior independent non-executive director

Ochre Bio has appointed Elaine Sullivan as senior independent non-executive director. She joins the Oxford-based RNA therapeutics company with a …

Appointment
clinical_trials_2

NICE recommends mirikizumab (Omvoh โ–ผ) for previously treated moderately to severely active Crohn’s disease 1

May 30, 2025
Research and Development Crohnโ€™s disease, Eli Lilly and Company, Gastrointestinal tract, Medicines and Healthcare products Regulatory Agency (MHRA)(, NHS England and Wales, National Institute for Health and Care Excellence (NICE), Omvoh, inflammatory bowel disease (IBD), mirikizumab

In the Phase 3 VIVID-1 trial, patients treated with mirikizumab experienced significant improvement in clinical remission and endoscopic response at …

News
Press release

DEBRA Research and Dermaliq Therapeutics collaborate to advance treatment for rare skin disorder

May 29, 2025
Research and Development DEBRA Research, Dermaliq Therapeutics, Dermatology, epidermolysis bullosa, non-profit organisation, skin disorders

Global non-profit organisation, DEBRA Research, and clinical dermatology company, Dermaliq Therapeutics, have announced a collaboration to advance drug development for …

News

Ryvu Therapeutics appoints Justyna ลปรณล‚tek to management board

May 29, 2025
Medical Communications, Research and Development Oncology, Ryvu Therapeutics, chief people officer, human resources, management board, oncology

Ryvu Therapeutics has promoted Justyna ลปรณล‚tek, chief people officer, to its management board. The appointment reflects the companyโ€™s focus on …

Appointment
clinical_trial_3

Neogap receives approval to administer full dose in cell therapy trial for colorectal cancer

May 28, 2025
Research and Development Neogap, Oncology, Swedish Medical Products Agency, colorectal cancer

Neogap Therapeutics has received regulatory approval from the Swedish Medical Products Agency to administer the full dose of its investigational …

News
handshake

TQ Therapeutics acquires Juno GmbH to support decentralised cell therapy platform

May 28, 2025
Mergers and Acquisitions Cell and Gene Therapy (CGT), Corporate, Juno GmbH, TQ Therapeutics, juno therapeutics

TQ Therapeutics (TQx) has acquired Juno Therapeutics GmbH, the German subsidiary of Juno Therapeutics, through a share purchase agreement. Juno …

News

UK Researcher Wins Prestigious IBSA Foundation Fellowship for Pioneering Dermatology Study

May 28, 2025
Medical Communications, Research and Development Dermatology, IBSA Foundation Fellowship, Institut Biochimique SA (IBSA), Masami Ando Kuri, Milan Italy, Wellcome Sanger Institute, dermatology

Masami Ando Kuri from the Wellcome Sanger Institute named one of six global winners of the 2024 IBSA Foundation Fellowships. …

News
Press release

Orientation Marketing appoints Sarah Darcy as sales operations executive

May 27, 2025
Marketing Services, Sales and Marketing Corporate, pharmaceutical marketing agency, sales operations executive

Orientation Marketing has announced the appointment of Sarah Darcy as sales operations executive. She joins the business-to-business (B2B) life sciencesย and …

Appointment
lab

The Royal Marsden launches AI radiology platform to revolutionise cancer care

May 27, 2025
Analytical & Laboratory Services, Market & Product Development, Medical Education, Research and Development AI, CARPL.ai., Institute of Cancer Research, NTT DATA, National Institute for Health and Care Research, Oncology, The Royal Marsden, oncology, radiology

The Royal Marsden, a world-leading cancer research centre, has launched a large-scale, AI-powered radiology platform designed to accelerate cancer detection …

News

MC2 Therapeutics appoints Trine Ahlgreen as new CEO

May 27, 2025
Research and Development, Sales and Marketing CEO, Corporate, MC2 Therapeutics, Skin, inflammatory skin conditions

MC2 Therapeutics, a Danish pharma company focused on topical therapies for inflammatory skin conditions, has appointed Trine Ahlgreen as CEO. …

Appointment
clinical_trials_2

Moderna doses first US patient in phase 1 trial of mRNA-4106 for solid tumours

May 23, 2025
Research and Development Moderna, Oncology, START Center for Cancer Research, US

The START Center for Cancer Research has dosed the first US participant in Modernaโ€™s phase 1 clinical trial evaluating mRNA-4106, …

News

NICE recommends treatment for chronic kidney disease, IgA nephropathy

May 23, 2025
Market & Product Development, Medical Communications, Research and Development IgA nephropathy, National Institute for Health and Care Excellence, Nephrology, kidney disease

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending CSL Viforโ€™s FILSPARI (sparsentan) for …

News
blood_test

CHMP issues positive opinion for Blenrep combinations in relapsed/refractory multiple myeloma

May 23, 2025
Market & Product Development, Medical Communications, Research and Development Blenrep, Committee for Medicinal Products for Human USE, European Medicines Agency, Oncology, multiple myeloma

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion …

News
handshake

Sanofi to acquire Vigil Neuroscience, adding Alzheimerโ€™s disease candidate to early-stage pipeline

May 23, 2025
Mergers and Acquisitions, Research and Development Alzheimer's disease, Neurology, Sanofi, Vigil Neuroscience, neurodegenerative diseases

Sanofi has announced an agreement to acquire Vigil Neuroscience, a biotech company focused on therapies for neurodegenerative diseases. The deal …

News

PL BioScience and DewCell sign LOI to Jointly Develop Artificial Human Platelets for Scalable, Animal-Free Cell Culture Media

May 23, 2025
Research and Development Animal-Free, Artificial Human Platelets, Corporate, DewCell, Haematology, Human Platelet Lysate, Letter of Intent, Oncology, PL Bioscience

PL BioScience and DewCell Biotherapeutics have signed a Letter of Intent (LOI) for the development and supply of artificial human …

News
Press release

Another Day Pharma announces successful Phase II trial results for BZ371A in post-prostatectomy erectile dysfunctionย 

May 22, 2025
Research and Development Another Day Pharma, Genito-Urinary system, clinical trial, erectile dysfunction, prostate cancer, prostatectomy

First-in-class therapeutic peptide BZ371A confirmed as effective and well-tolerated  20 May 2025. Another Day Pharma Ltd, a company developing innovative …

News
Press release

Tiakis Biotech appoints Christoph Schmidt to supervisory board

May 22, 2025
Research and Development Cardiology, Tiakis Biotech, cardiovascular diseases, pulmonary arterial hypertension

Tiakis Biotech has announced the appointment of Christoph Schmidt to its supervisory board. Based in Kiel, Germany, the clinical-stage biotech …

Appointment

NICE recommends Pfizerโ€™s new once-weekly treatment for haemophilia B on NHS

May 22, 2025
Market Access, Research and Development Haematology, Hympavzi, NHS, NICE, Pfizer, haemophilia B, marstacimab

Walton Oaks, 21stย May 2025ย โ€“ย Pfizer Ltd announced today that the National Institute for Health and Care Excellence (NICE) has published final …

News
Press release

Five Facts about mental health

May 21, 2025
Medical Communications, Medical Education, Research and Development European Commission, Pharmacy, Psychiatry, mental health, mental health condition

32% of people suffer from at least one mental health issue, with daily struggles like financial and job insecurity being …

Feature
The Gateway to Local Adoption Series

Latest content

Just โ€“ Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026